Antibody Titers After a Third and Fourth SARS-CoV-2 BNT162b2 Vaccine Dose in Older Adults.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 35862048.
- Also identified by DOI 10.1001/jamanetworkopen.2022.23090 and PMC identifier 9305380.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This cohort study evaluates the response to a third and fourth SARS-CoV-2 BNT162b2 vaccine dose among individuals aged 60 years or older by evaluating antispike immunoglobulin G antibody titers before and after each dose.
Medical subject headings
- COVID-19
- COVID-19 Vaccines